This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: University of California. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Hsing-Ju Tsai: Innovator in Soluble Epoxide Hydrolase Inhibitors
Introduction
Hsing-Ju Tsai is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of pharmacology, particularly in the development of inhibitors for soluble epoxide hydrolase (sEH). With a total of 3 patents to his name, Tsai's work is paving the way for new treatments for various diseases.
Latest Patents
Among his latest patents, Tsai has developed conformationally restricted urea inhibitors of soluble epoxide hydrolase. These inhibitors incorporate multiple pharmacophores and are designed to be effective in treating diseases. His innovative approach to drug design showcases the potential for targeted therapies in modern medicine.
Career Highlights
Hsing-Ju Tsai is affiliated with the University of California, where he continues to advance research in his field. His work has garnered attention for its potential impact on therapeutic strategies, particularly in the context of diseases that can be treated through modulation of the sEH pathway.
Collaborations
Some of his notable coworkers include Bruce D Hammock and Paul Daniel Jones. Their collaborative efforts contribute to the ongoing research and development of effective pharmacological solutions.
Conclusion
Hsing-Ju Tsai's innovative work in the field of soluble epoxide hydrolase inhibitors exemplifies the importance of research in developing new therapeutic options. His contributions are vital to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile